- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Chimeric anti-CD20 monoclonal antibody(SCT400)
Total 100895 results
-
David HoUS Military HIV Research Program; Henry M. Jackson Foundation for the Advancement... and other collaboratorsRecruitingHIV-1-infectionTanzania
-
University Hospital, GrenobleRecruitingPseudomonas Aeruginosa | Multi-antibiotic ResistanceFrance
-
EuroPharma, Inc.Botalys SACompleted
-
Assistance Publique - Hôpitaux de ParisRoche Pharma AGCompletedComparison Between a Long Term and a Conventional Maintenance Treatment With Rituximab (MAINRITSAN3)ANCA-associated VasculitidesFrance
-
Genor Biopharma Co., Ltd.RecruitingCLL | B Cell NHLAustralia
-
Hospices Civils de LyonRecruitingNMDAR Antibody-associated Auto-immune EncephalitisFrance
-
Nanjing Leads Biolabs Co.,LtdRecruitingAdvanced Malignant TumorsChina
-
Abramson Cancer Center of the University of PennsylvaniaCompletedPleural Malignant MesotheliomaUnited States
-
TruCare Internal Medicine & Infectious DiseaseGilead SciencesCompleted
-
Chinese SLE Treatment And Research GroupRecruitingANCA-associated Vasculitis | Maintenance TherapyChina
-
Istituto Giannina GasliniRecruiting
-
Shanghai Longyao Biotechnology Inc., Ltd.Xuzhou Medical University; Shanghai Jiao Tong University School of MedicineUnknownRecurrent or Refractory B Cell MalignancyChina
-
Emory UniversityNational Cancer Institute (NCI)Completed
-
Yancheng First People's HospitalRecruiting
-
The First Affiliated Hospital of Soochow UniversityRecruitingRelapsed/Refractory Peripheral T-cell LymphomaChina
-
Peking University Third HospitalRecruitingProliferative Diabetic RetinopathyChina
-
Corixa CorporationCompletedMantle Cell LymphomaUnited States
-
University of GeorgiaRecruitingMessage Exposure (Sequence: Regular Then Flavor) | Message Exposure (Sequence: Flavor Then Regular) | No Message Exposure (Control Condition)United States
-
Chinese SLE Treatment And Research GroupPeking Union Medical College HospitalRecruitingANCA Associated VasculitisChina
-
Akesobio Australia Pty LtdCompletedCoronavirus Disease 2019 (COVID-19)New Zealand
-
Second Affiliated Hospital, School of Medicine,...RecruitingOvarian Cancer | Neoadjuvant Chemotherapy | Anti-PD-1 | Neoadjuvant ImmunotherapyChina
-
Innate PharmaCompletedSmoldering Multiple MyelomaUnited States
-
St. Jude Children's Research HospitalUniversity of Wisconsin, MadisonCompletedMelanoma | Osteosarcoma | Neuroblastoma | Ewing Family of TumorsUnited States
-
University of North Carolina, Chapel HillNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)SuspendedANCA Associated VasculitisUnited States
-
AstraZenecaIqvia Pty LtdActive, not recruitingRespiratory Syncytial Virus InfectionsJapan
-
Humanis Saglık Anonim SirketiCompleted
-
Pierre Fabre Dermo CosmetiqueCompleted
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Universitaire Ziekenhuizen KU LeuvenCompletedMandibular Prosthesis UserBelgium
-
The Lymphoma Academic Research OrganisationGrupo Español de Linfomas y Transplante Autólogo de Médula Ósea; Swiss Group... and other collaboratorsRecruitingFollicular LymphomaBelgium, France, Germany, Portugal, Spain
-
Beijing VDJBio Co., LTD.RecruitingIdiopathic Multicentric Castleman's DiseaseChina
-
University Hospital, LilleTakeda; Laboratoire français de Fractionnement et de Biotechnologies; VitalAire; French Healthcare network for rare immune and hematological disorders (MARIH)Not yet recruitingSpecific Antibody Deficiency | Predominantly Antibody Deficiencies
-
Human Genome Sciences Inc., a GSK CompanyGlaxoSmithKlineCompletedVasculitisUnited States, Australia, France, Spain, Italy, Peru, Belgium, Canada, Germany, Romania, Mexico, United Kingdom, Hungary, Ireland, Poland, Switzerland, Czechia, Russian Federation, Norway, Sweden
-
Tianjin Medical University General HospitalNot yet recruitingMyelin Oligodendrocyte Glycoprotein Antibody-associated DiseaseChina
-
Bio-Thera SolutionsTerminatedAdvanced Solid TumorAustralia
-
Shanghai Junshi Bioscience Co., Ltd.Sponsor GmbHRecruitingActive Ankylosing SpondylitisChina
-
Genor Biopharma Co., Ltd.RecruitingAlveolar Soft Part SarcomaChina
-
Innate PharmaCompleted
-
National Cancer Institute (NCI)CompletedChronic Lymphocytic Leukemia | Recurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Jonsson Comprehensive Cancer CenterEli Lilly and Company; Genentech, Inc.Active, not recruitingMetastatic Lung Non-Small Cell Carcinoma | Refractory Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer American Joint Committee on Cancer (AJCC) v8 | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8United States
-
SpectronRXJanssen Research & Development, LLC; Invicro; Tomopath Inc.TerminatedMetastatic Disease | Castration-Resistant Prostatic CancerUnited States
-
Shanghai Biomabs Pharmaceutical Co., Ltd.Completed
-
Shanghai Huaota Biopharmaceutical Co., Ltd.RecruitingGeneralized Pustular Psoriasis (GPP)China
-
Jiangsu T-Mab Biopharma Co.,LtdUnknownNeovascular Age-Related Macular DegenerationChina
-
Catholic Relief ServicesCenters for Disease Control and PreventionCompleted
-
Lei LiRecruitingChemotherapy | Recurrent Cervical Carcinoma | Immune Checkpoint Inhibitors | Anti-PD-1 Antibody | Persistent Advanced Cervical Carcinoma | Albumin-bound PaclitaxelChina
-
National Cancer Institute (NCI)CompletedCarcinoma, Hepatocellular | Hepatocellular Carcinoma | Hepatocellular CancerUnited States
-
BayerCompletedLymphoma, B-Cell | Non-Hodgkin's Lymphoma | Lymphoma, Low-GradeJapan
-
University of WashingtonBayerTerminatedNon-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Lymphoid LeukemiaUnited States
-
National Cancer Institute (NCI)Not yet recruitingClassic Follicular Lymphoma | Follicular Lymphoma With Unusual Cytological Features